Novo Nordisk

Danish global pharmaceutical company focused on diabetes, obesity and chronic disease care.

Added by Maílis Carrilho on February 9th, 2026

Summary

Novo Nordisk is a Danish multinational pharmaceutical company specializing in diabetes care, obesity treatment, and other serious chronic diseases, including rare blood disorders and endocrine conditions. The company is a global leader in insulin and GLP-1 therapies and has made sustainability and access to healthcare central to its long-term strategy.